Reducing The Growing Burden Of Cardiovascular Disease In The Developing World
- 1 January 2007
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 26 (1), 13-24
- https://doi.org/10.1377/hlthaff.26.1.13
Abstract
Cardiovascular disease (CVD) has become the number-one cause of death in the developing world. This epidemic has the potential to place a large social and economic burden on developing countries, where CVD tends to strike those in their prime working years. Since resources for managing CVD are limited, it is important that interventions be guided by cost-effectiveness results for low- and middle-income countries. Despite the burden, cost-effective strategies exist at the population and individual levels for reducing CVD. Integral to all personal intervention strategies is an adequate assessment of the underlying risk of disease.Keywords
This publication has 23 references indexed in Scilit:
- Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysisThe Lancet, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Cardiovascular Disease in the Developing World and Its Cost-Effective ManagementCirculation, 2005
- Cost-Effectiveness Analysis of Hypertension Guidelines in South AfricaCirculation, 2005
- Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IVJournal of Human Hypertension, 2004
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- Global Burden of Cardiovascular DiseasesCirculation, 2001
- HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failureHeart, 2000
- Cost-effectiveness analysis in heart disease, part II: Preventive therapiesProgress in Cardiovascular Diseases, 1995
- The North Karelia Project: 15 Years of Community-Based Prevention of Coronary Heart DiseaseAnnals of Medicine, 1989